Travere Therapeutics, Inc. · NASDAQ:TVTX
Reed Elizabeth E sold 10,000 Travere Therapeutics, Inc. shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 2, 2026
On Apr 1, 2026, Reed Elizabeth E (Chief Legal Officer and GC) sold 10,000 Travere Therapeutics, Inc. shares at US$30.00 for US$300K under a trading plan, leaving 105,211 shares. Filed Apr 2, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$30.00
- Value
- US$300K
- Holding after
- 105,211 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Legal Officer and GC
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Option exercise | 10,000 | US$15.46 | 115,211 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 10,000 | US$30.00 | 105,211 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Reed Elizabeth E
- Travere Therapeutics, Inc. shareholders
- Form 4 · Reed Elizabeth E · Sep 17, 2026
- Form 4 · Reed Elizabeth E · May 6, 2026
- Form 4 · Reed Elizabeth E · Apr 15, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026